Company profile
Allogene Therapeutics, Inc. Insider Trading
ALLOEvery SEC Form 4 insider trading filing for Allogene Therapeutics, Inc. (ALLO) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001737287
- Filings
- 90
- Insiders
- 17
- Last filing
- 2026-08-21
Activity summary
No insider transactions in the last 30 days. The most recent was on August 21, 2026, when Earl Martin Douglas sold 29,697 shares. 90 filings from 17 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Allogene Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $8.0M.
90 day insight
Over the last 90 days, Allogene Therapeutics, Inc. insiders bought $0 (2 transactions) and sold $63K (1 transaction).
- Most active insider: Zachary Roberts with 2 transactions totaling $0.
- Largest single sale: $63K by Earl Martin Douglas on Aug 21, 2026.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Earl Martin Douglas | ALLO | Sale | 29,697 | $2.12 | $63K |
| Jul 1, 2026 | Zachary Roberts | ALLO | Award | 134,530 | — | — |
| Jul 1, 2026 | Zachary Roberts | ALLO | Award | 476,190 | — | — |
| Jun 18, 2026 | Elizabeth A. Barrett | ALLO | Award | 95,400 | — | — |
| Jun 18, 2026 | Franz B Humer | ALLO | Award | 95,400 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ALLO" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Allogene Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →